Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study

被引：0
|
作者：
Xinqing Lin
Haiyi Deng
Suyang Li
Xiaohong Xie
Chao Chen
Longqiu Cai
Yilin Yang
Guihuan Qiu
Zhanhong Xie
Yinyin Qin
Ming Liu
Chengzhi Zhou
机构：
[1] National Clinical Research Centre for Respiratory Disease,State Key Laboratory of Respiratory Disease
[2] Guangzhou Institute of Respiratory Health,undefined
[3] First Affiliated Hospital,undefined
[4] Guangzhou Medical University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
Squamous non-small-cell lung cancer; Sintilimab; Chemotherapy; Real world;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：757 / 764
页数：7
相关论文
共 50 条
  • [1] Sintilimab with chemotherapy as first-line treatment for locally advanced or metastatic squamous non-small-cell lung cancer: a real-world data study
    Lin, Xinqing
    Deng, Haiyi
    Li, Suyang
    Xie, Xiaohong
    Chen, Chao
    Cai, Longqiu
    Yang, Yilin
    Qiu, Guihuan
    Xie, Zhanhong
    Qin, Yinyin
    Liu, Ming
    Zhou, Chengzhi
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (02) : 757 - 764
  • [2] Sintilimab plus chemotherapy for first-line treatment of advanced or metastatic nonsquamous non-small-cell lung cancer: network meta-analysis
    Molife, Cliff
    Brnabic, Alan
    Stefaniak, Victoria J.
    Belger, Mark A.
    Gruver, Kristi
    Chen, Jing, V
    Souri, Saman
    Blumenschein, George R.
    [J]. IMMUNOTHERAPY, 2023, 15 (04) : 293 - 309
  • [3] Real-world outcomes of immunotherapy with or without chemotherapy in first-line treatment of advanced non-small cell lung cancer
    Pelicon, Veronika
    Cufer, Tanja
    Knez, Lea
    [J]. FRONTIERS IN ONCOLOGY, 2023, 13
  • [4] Real-World Study of Patients With EGFR Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer Treated With First-Line Osimertinib
    Nieva, J.
    Taylor, A.
    Servidio, L.
    Sun, P.
    Okhuoya, P.
    Horvat, P.
    Tolani, E.
    Magee, K.
    Mathur, R.
    Balakrishna, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1113 - S1113
  • [5] First-line treatment for advanced non-small-cell lung cancer
    Laskin, Janessa J.
    Sandler, Alan B.
    [J]. ONCOLOGY-NEW YORK, 2005, 19 (13): : 1671 - 1676
  • [6] Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer
    Levy, B. P.
    Signorovitch, J. E.
    Yang, H.
    Patterson-Lomba, O.
    Xiang, C. Q.
    Parisi, M.
    [J]. CURRENT ONCOLOGY, 2019, 26 (03) : E300 - E308
  • [7] Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Fleeman, N.
    Bagust, A.
    McLeod, C.
    Greenhalgh, J.
    Boland, A.
    Dundar, Y.
    Dickson, R.
    Smith, C. Tudur
    Davis, H.
    Green, J.
    Pearson, M.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 47 - 53
  • [8] ORIENT-12: Sintilimab plus gemcitabine and platinum (GP) as first-line (1L) treatment for locally advanced or metastatic squamous non-small-cell lung cancer (sqNSCLC)
    Zhou, C.
    Wu, L.
    Fan, Y.
    Wang, Z.
    Liu, L.
    Chen, G.
    Zhang, L.
    Huang, D.
    Cang, S.
    Yang, Z.
    Zhou, J.
    Zhou, C.
    Li, B.
    Li, J.
    Fan, M.
    Zhang, W.
    Yang, W.
    Wang, S.
    Zhou, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1186 - S1186
  • [9] Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
    Brown, T.
    Boland, A.
    Bagust, A.
    Oyee, J.
    Hockenhull, J.
    Dundar, Y.
    Dickson, R.
    Ramani, V. S.
    Proudlove, C.
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 71 - 79
  • [10] WEIGHT GAIN DURING FIRST-LINE CHEMOTHERAPY FOR LOCALLY ADVANCED AND METASTATIC NON-SMALL-CELL LUNG CANCER IS ASSOCIATED WITH IMPROVED SURVIVAL
    Ferreira, Iva
    Azeem, Mohammed
    Basu, Sanjib
    Sims, Shannon
    Batus, Marta
    Bonomi, Philip
    Fidler, Mary Jo
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1178 - S1179
12345